87. Jahrestagung der Deutschen Gesellschaft für Kardiologie

Freitag, 9. April 2021 (Posterwalk 3) 19:30-20:30

Postervorträge

Aortenklappenstenose - Neue Mechanismen und Interventionen - From bench to bedside

Diskussionsleiter: S. Jung (Erlangen), W.-K. Kim (Bad Nauheim)

(P1300) Elucidating the Impact of Flow during Pathogenesis of Calcific Aortic Valve Disease
    P. R. Goody, D. Nehl, M. R. Hosen, D. Goody, A. Zietzer, G. Nickenig, A. Pfeifer, F. Jansen (Bonn)
(P1301) Effect of transcatheter aortic valve implantation on left ventricular pressure overload indicated by inflammatory biomarkers in high-risk patients
    L. Schulz, O. Dörr, S. Keranov, C. Liebetrau, T. Keller, W.-K. Kim, F. J. Hofmann, P. Bauer, C. Troidl, S. Voß, C. W. Hamm, H. Nef (Gießen, Bad Nauheim)
(P1302) Impact of on-clopidogrel platelet reactivity on incidence of peri-interventional bleeding in patients undergoing transcatheter aortic valve implantation
    A. Kille, T. Nührenberg, J. Hromek, C. M. Valina, D. Trenk, F.-J. Neumann, W. Hochholzer (Bad Krozingen)
(P1303) Einfluss der Transkatheter-Aortenklappenimplantation (TAVI) auf die Thrombinbildung und Plättchenfunktion
    P. Mourikis, L. K. Dannenberg, S. Zako, C. Helten, R. M'Pembele, H. Richter, T. Hohlfeld, C. Jung, T. Zeus, M. Kelm, V. Veulemans, A. Polzin (Düsseldorf)
(P1304) Metabolomic profiling in patients with low-gradient and paradoxical low-flow low-gradient aortic stenosis and the impact of transcatheter aortic valve implantation
    L. Bäz, D. Haase, S. Neugebauer, T. Bekfani, J. Bogoviku, S. Möbius-Winkler, M. Franz, C. Schulze (Jena, Magdeburg)
(P1305) Aging mice with global lack of eNOS exhibit spontaneous development of aortic valve stenosis characterized by valve leaflet thickening, fibrosis and calcification but not inflammation
    K. Becker, I. Gyamfi-Poku, R. J. Erkens, G. Wolff, M. Kelm, C. Quast (Düsseldorf)
(P1306) Transcatheter aortic valve replacement leads to plasmatic alterations in patients resulting in enhanced endothelial function in aortic ring bioassay
    M. Nankinova, I. Gyamfi-Poku, T. Zeus, M. Kelm, C. Quast (Düsseldorf)
(P1307) Neutral Sphingomyelinase 2 controls the development of aortic valve stenosis.
    A. Zietzer, S. T. Niepmann, L. Reese, M. R. Hosen, P. R. Goody, S. Zimmer, G. Nickenig, F. Jansen (Bonn)
(P1308) Cell-free hemoglobin plays a crucial role in systemic endothelial dysfunction in an experimental model of aortic valve stenosis
    I. Gyamfi-Poku, R. Chennupati, K. Becker, A. Gödecke, M. Kelm, C. Quast (Düsseldorf)
(P1309) Circulating Chaperones in Patients with Aortic Valve Stenosis Undergoing TAVR: Impact of Concomitant Chronic Kidney Disease
    A. Aksoy, B. Al-Kassou, M. Al Zaidi, J. Shamekhi, A. Sedaghat, M. U. Becher, H. Treede, J.-M. Sinning, S. Zimmer, G. Nickenig, V. Tiyerili (Bonn, Köln)